Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases

BACKGROUND: Allergen immunotherapy (AIT) is the only causal therapy for IgE-mediated allergy. There is less evidence about the safety and efficacy of AIT especially subcutaneous immunotherapy (SCIT) in children under 5 years old. We aimed to investigate the side effects and associated risk factors o...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Udgivet i:	Ital J Pediatr
Main Authors:	Yang, Yaqi, Ma, Dongxia, Huang, Nan, Li, Wenjing, Jiang, Qing, Wang, Yin, Wang, Xiaolong, Yang, Lin, Zhu, Rongfei
Format:	Artigo
Sprog:	Inglês
Udgivet:	BioMed Central 2021
Fag:	Research
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC8063484/ https://ncbi.nlm.nih.gov/pubmed/33892756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13052-021-01046-z
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases

Lignende værker